585 related articles for article (PubMed ID: 34160242)
1. Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.
Van Leuven JT; Gonzalez AJ; Ijezie EC; Wixom AQ; Clary JL; Naranjo MN; Ridenhour BJ; Miller CR; Miura TA
mSphere; 2021 Jun; 6(3):e0047921. PubMed ID: 34160242
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.
Gonzalez AJ; Ijezie EC; Balemba OB; Miura TA
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232180
[TBL] [Abstract][Full Text] [Related]
3. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
[TBL] [Abstract][Full Text] [Related]
4. Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection.
Cox G; Gonzalez AJ; Ijezie EC; Rodriguez A; Miller CR; Van Leuven JT; Miura TA
Front Immunol; 2022; 13():886611. PubMed ID: 35711419
[TBL] [Abstract][Full Text] [Related]
5. Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.
Buchholz UJ; Ward JM; Lamirande EW; Heinze B; Krempl CD; Collins PL
J Virol; 2009 Feb; 83(4):1969-80. PubMed ID: 19052095
[TBL] [Abstract][Full Text] [Related]
6. Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.
Percopo CM; Ma M; Brenner TA; Krumholz JO; Break TJ; Laky K; Rosenberg HF
J Immunol; 2019 Feb; 202(3):871-882. PubMed ID: 30578308
[TBL] [Abstract][Full Text] [Related]
7. Coinfection with Blood-Stage Plasmodium Promotes Systemic Type I Interferon Production during Pneumovirus Infection but Impairs Inflammation and Viral Control in the Lung.
Edwards CL; Zhang V; Werder RB; Best SE; Sebina I; James KR; Faleiro RJ; de Labastida Rivera F; Amante FH; Engwerda CR; Phipps S; Haque A
Clin Vaccine Immunol; 2015 May; 22(5):477-83. PubMed ID: 25716232
[TBL] [Abstract][Full Text] [Related]
8. A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.
Shepardson K; Larson K; Cho H; Johns LL; Malkoc Z; Stanek K; Wellhman J; Zaiser S; Daggs-Olson J; Moodie T; Klonoski JM; Huber VC; Rynda-Apple A
Viral Immunol; 2019 Apr; 32(3):131-143. PubMed ID: 30822217
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary eosinophils and their role in immunopathologic responses to formalin-inactivated pneumonia virus of mice.
Percopo CM; Qiu Z; Phipps S; Foster PS; Domachowske JB; Rosenberg HF
J Immunol; 2009 Jul; 183(1):604-12. PubMed ID: 19542471
[TBL] [Abstract][Full Text] [Related]
10. S. mansoni bolsters anti-viral immunity in the murine respiratory tract.
Scheer S; Krempl C; Kallfass C; Frey S; Jakob T; Mouahid G; Moné H; Schmitt-Gräff A; Staeheli P; Lamers MC
PLoS One; 2014; 9(11):e112469. PubMed ID: 25398130
[TBL] [Abstract][Full Text] [Related]
11. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.
Easton AJ; Scott PD; Edworthy NL; Meng B; Marriott AC; Dimmock NJ
Vaccine; 2011 Mar; 29(15):2777-84. PubMed ID: 21320545
[TBL] [Abstract][Full Text] [Related]
12. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection.
Gabryszewski SJ; Bachar O; Dyer KD; Percopo CM; Killoran KE; Domachowske JB; Rosenberg HF
J Immunol; 2011 Jan; 186(2):1151-61. PubMed ID: 21169550
[TBL] [Abstract][Full Text] [Related]
13. Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation.
Cortjens B; Lutter R; Boon L; Bem RA; van Woensel JB
PLoS One; 2016; 11(12):e0168779. PubMed ID: 28005954
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.
Garcia-Crespo KE; Chan CC; Gabryszewski SJ; Percopo CM; Rigaux P; Dyer KD; Domachowske JB; Rosenberg HF
Antiviral Res; 2013 Mar; 97(3):270-9. PubMed ID: 23274789
[TBL] [Abstract][Full Text] [Related]
15. IL-17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus.
Liu X; Nguyen TH; Sokulsky L; Li X; Garcia Netto K; Hsu AC; Liu C; Laurie K; Barr I; Tay H; Eyers F; Foster PS; Yang M
Respirology; 2021 Nov; 26(11):1049-1059. PubMed ID: 34472161
[TBL] [Abstract][Full Text] [Related]
16. Intranasal treatment with a novel immunomodulator mediates innate immune protection against lethal pneumonia virus of mice.
Martinez EC; Garg R; Shrivastava P; Gomis S; van Drunen Littel-van den Hurk S
Antiviral Res; 2016 Nov; 135():108-119. PubMed ID: 27771388
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Analysis Reveals Priming of The Host Antiviral Interferon Signaling Pathway by Bronchobini
Reamon-Buettner SM; Niehof M; Hirth N; Danov O; Obernolte H; Braun A; Warnecke J; Sewald K; Wronski S
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067687
[TBL] [Abstract][Full Text] [Related]
18. Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
Schwab LSU; Do THT; Pilapitiya D; Koutsakos M
J Virol; 2024 Jun; 98(6):e0160423. PubMed ID: 38780249
[TBL] [Abstract][Full Text] [Related]
19. Unique nonstructural proteins of Pneumonia Virus of Mice (PVM) promote degradation of interferon (IFN) pathway components and IFN-stimulated gene proteins.
Dhar J; Barik S
Sci Rep; 2016 Dec; 6():38139. PubMed ID: 27905537
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pneumonia virus of mice as a possible human pathogen.
Brock LG; Karron RA; Krempl CD; Collins PL; Buchholz UJ
J Virol; 2012 May; 86(10):5829-43. PubMed ID: 22438539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
